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Introduction
The centrosomal protein C-Nap1, also known as Cep250
(Mack et al., 1998) has been implicated in the cell-cycle-
regulated cohesion of microtubule-organizing centers (Fry et
al., 1998a; Mayor et al., 2000). This 281 kDa protein consists
mainly of domains predicted to form coiled coil structures.
During interphase, C-Nap1 localizes to proximal ends of both
parental centrioles, but it dissociates from these structures at
the onset of mitosis. Re-association with centrioles then occurs
in late telophase or at the very beginning of G1 phase, when
daughter cells are still connected by post-mitotic bridges
(Mayor et al., 2000). Electron microscopic studies performed
on isolated centrosomes suggest that a proteinaceous linker
connects parental centrioles (Paintrand et al., 1992).
Considering the localization of C-Nap1 (Fry et al., 1998a;
Mayor et al., 1999), it is attractive to speculate that C-Nap1
constitutes a docking site for such a linker, and this view is
supported by functional studies. Microinjection of anti-C-Nap1
antibodies into tissue culture cells induces centrosome splitting
(i.e. the separation of parental centrioles by a distance of
several microns), and centrosome splitting can also be induced
by overexpression of C-Nap1 truncation mutants that
presumably exert a dominant-negative effect (Mayor et al.,
2000). Thus, a current model holds that C-Nap1 is part of a
linker structure that assures the cohesion of duplicated
centrosomes during interphase, but that is dismantled upon
centrosome separation at the onset of mitosis. 
C-Nap1 is known to interact with the mammalian serine/
threonine kinase Nek2 (Fry et al., 1998a), a member of the
NIMA kinase family (Schultz et al., 1994). Both Nek2
abundance and activity are cell cycle regulated, with peak
levels in S/G2 and low activity in nocodazole-arrested and G1
phase cells (Fry et al., 1995). Both C-Nap1 and Nek2 co-
localize at the centrosome (Fry et al., 1998a), and C-Nap1 most
likely constitutes a physiological substrate of Nek2 (Fry et al.,
1998a). Interestingly, protein phosphatase 1 (PP1) interacts
with Nek2 and can de-phosphorylate both C-Nap1 and Nek2
(Helps et al., 2000). Thus, it is attractive to speculate that
phosphorylation may regulate C-Nap1 function, and that the
phosphorylation state of C-Nap1 may depend on the balance
of Nek2 and PP1 activity. In support of such a model,
centrosome splitting can be induced by overexpression of
active Nek2 (Fry et al., 1998b) as well as by drug-induced
inhibition of PP1 (Meraldi and Nigg, 2001). From a cell cycle
perspective, it is intriguing that PP1 is inhibited at the onset of
mitosis, possibly as a direct consequence of phosphorylation
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The centrosomal protein C-Nap1 is thought to play an
important role in centrosome cohesion during interphase
of the cell cycle. At the onset of mitosis, when centrosomes
separate for bipolar spindle formation, C-Nap1 dissociates
from centrosomes. Here we report the results of
experiments aimed at determining whether the dissociation
of C-Nap1 from mitotic centrosomes is triggered by
proteolysis or phosphorylation. Specifically, we analyzed
both the cell cycle regulation of endogenous C-Nap1 and
the fate of exogenously expressed full-length C-Nap1.
Western blot analyses suggested a reduction in the
endogenous C-Nap1 level during M phase, but studies using
proteasome inhibitors and destruction assays performed in
Xenopus extracts argue against ubiquitin-dependent
degradation of C-Nap1. Instead, our data indicate that the
mitotic C-Nap1 signal is reduced as a consequence of M-
phase-specific phosphorylation. Overexpression of full-
length C-Nap1 in human U2OS cells caused the formation
of large structures that embedded the centrosome and
impaired its microtubule nucleation activity. Remarkably,
however, these centrosome-associated structures did not
interfere with cell division. Instead, centrosomes were
found to separate from these structures at the onset of
mitosis, indicating that a localized and cell-cycle-regulated
activity can dissociate C-Nap1 from centrosomes. A prime
candidate for this activity is the centrosomal protein kinase
Nek2, as the formation of large C-Nap1 structures was
substantially reduced upon co-expression of active Nek2.
We conclude that the dissociation of C-Nap1 from mitotic
centrosomes is regulated by localized phosphorylation
rather than generalized proteolysis. 
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by Cdk1 (Puntoni and Villa-Moruzzi, 1997). As a result, Nek2
is expected to prevail and phosphorylate C-Nap1 specifically
at the onset of mitosis. 
Although attractive, the above model remains speculative. In
particular, there is no previous evidence to indicate that
endogenous C-Nap1 is phosphorylated in vivo, let alone that it
is phosphorylated in a cell-cycle-specific manner. Furthermore,
there is increasing evidence to suggest that ubiquitin-dependent
proteolysis of centrosomal proteins plays an important role in
the regulation of centrosome structure and function (Freed
et al., 1999; Gstaiger et al., 1999; Fabunmi et al., 2000). In
the present study, we thus asked whether proteolysis or
phosphorylation is more likely to explain the cell-cycle-
regulated dissociation of C-Nap1. To this end, we studied both
the cell cycle regulation of endogenous C-Nap1, and the
consequences of overexpressing full-length exogenous C-
Nap1. Our results provide no evidence for proteolytic
degradation of C-Nap1. Instead, they strengthen the view that




For construction of truncated versions of myc-tagged C-Nap1 (T3-7),
the kC-Nap1 plasmid (Mayor et al., 2000) was used. During these
constructions, linker sequences were generated both between the myc
tag and the C-Nap1 fragment, and upstream of the stop codon. These
sequences, as well as the amino acid (aa) sequence of the
corresponding C-Nap1 mutants, are as follows: T3 (aa 243-1985;
MNSCSPSRA, DS), T4 (aa 1-1986; MNSCSPSRA, DR), T5 (aa 1-
1182; MNSCSPSRA, GGIH), T6 (aa 1248-2442; MNSCSPGDQ, –),
T7 (aa 243-2442;MNSCS; –). All mutant constructs were subcloned
into the pBK-CMV vector. For fusion to the enhanced GFP marker,
C-Nap1 was excised from the kC-Nap1 plasmid using EcoRV and
SacII and introduced into the sites BspEI (blunted with Klenow) and
SacII of pEGFP-C1 (Clontech), creating a 6 aa linker (SGSRAA). The
GFP-C-Nap1 fusion protein was further subcloned into pcDNA4/TO
(Invitrogen) using, respectively, AgeI (blunted with Klenow) and
BamHI, and HindIII (blunted with Klenow) and BamHI.
Cell culture
HeLa and U2OS osteosarcoma cells were grown at 37°C in a 7% or
5% CO2 atmosphere in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% heat-inactivated fetal calf serum
(FCS) and penicillin-streptomycin (100 i.u./ml and 100 m g/ml,
respectively). HeLa cells were treated with 2 mM thymidine, 1.6
m g/ml aphidicolin, 0.5 m g/ml nocodazole, 100 m M monastrol, 10 or
40 m g/ml MG132 (C-2211), 10 or 25 m g/ml MG115 (C-6706) or
5m g/ml ALLN (A-6185). (Monastrol was a kind gift from Dr T.
Mayer, all other drugs from Sigma.) For synchronization at G1/S,
dishes with 20% confluent cells were treated for 14 hours with
thymidine, washed three times with PBS, reincubated with normal
medium for 10 hours and, finally, treated for 14 hours with
aphidicolin. For synchronization in mitosis, cells were released for 10
hours from the G1/S block, treated with nocodazole or monastrol for
4.5 hours and collected by mechanical shake off. Alternatively, mitotic
cells were collected by mechanical shake off after 16 hours of
nocodazole treatment. For synchronization in G1, cells blocked with
nocodazole in mitosis were collected, washed and released for 6 hours
into normal medium. Mechanical shake off was then applied to
discard non-adherent cells. 
For transient transfection studies, U2OS cells were seeded onto
HCl-treated glass coverslips and then transfected with 5 m g of plasmid
DNA, using calcium phosphate precipitates as previously described
(Seelos, 1997). Cells were fixed 24 or 36 hours later in cold methanol
(–20°C) for 6 minutes. To arrest cells in mitosis, a mutated chicken
cyclin B2 in pCMV-neo was used (arginine in position 32 converted
to serine, Gallant and Nigg, 1992). Co-transfection was achieved by
adding 2.5 m g of each of the two plasmid DNAs. When active (wt)
and inactive Nek2 kinases in pRc-CMV (Fry et al., 1998b) were co-
transfected with mycC-Nap1, 3.5 m g and 1.5 m g of plasmid DNA were
used for Nek2 and C-Nap1, respectively.
Enhanced GFP-C-Nap1 was stably integrated into T-REx modified
U2OS cells according to manufacturer’s instructions (Invitrogen), and
cells were cloned by limiting dilution. Expression of the GFP-C-Nap1
fusion protein was induced for 24 hours with 1 m g/ml of tetracycline
(Invitrogen, Q100-19). 
Immunofluorescence microscopy
Cells were washed with PBS and blocked for 20 minutes with 1%
BSA in PBS at room temperature, before being incubated with
primary antibodies for 1 hour at room temperature. Primary antibodies
were affinity-purified anti-C-Nap1 (C-Ab, 0.5 m g/ml), GTU-88 anti-
g -tubulin mAb (1:1000; Sigma), anti- a -tubulin mAb (1:2000; Sigma),
9E10 anti-myc mAb (undiluted tissue culture supernatant) and GT335
anti-polyglutamylated tubulin mAb (1:2000; a kind gift of B. Edde,
CNRS, Montpellier, France). Secondary antibodies were biotinylated
donkey anti-rabbit or goat anti-mouse IgG (1:200; Amersham),
followed by Texas-Red-conjugated streptavidin (1:100; Amersham),
FITC-conjugated goat anti-mouse Fab fragment (1:100; Sigma),
FITC-conjugated goat anti-rabbit (1:100; Sigma) and Alexa-Fluor-
488-conjugated goat anti-mouse IgG (1:1000; Molecular Probes). All
antibodies were diluted in 3% BSA in PBS. Immunofluorescence
microscopy was performed using a Zeiss Axioplan II microscope and
Neofluar 40 · or Apochromat 63 · oil immersion objectives.
Photographs were taken using Quantix 1400 (Photometrics) or
Micromax (Princeton Instruments) CCD cameras and IP-Lab or
Metaview (Universal Imaging) software.
Immunochemical techniques
To prepare extracts for immunoblotting, cells were lysed in RIPA
buffer (50 mM Tris-HCl, pH 8, 1% Nonidet P40, 0.5% deoxycholic
acid, 0.1% SDS, 150 mM NaCl, 1 mM PMSF, 1 m g/ml aprotinin, 1
m g/ml leupeptin, 1 m g/ml pepstatin A, 20 mM b -glycerophosphate, 20
mM NaF and 0.3 mM sodium vanadate). Samples were left for 30
minutes on ice, passed 10 times through a 27G needle and centrifuged
at 16,000 g for 10 minutes at 4°C. Protein concentrations were
determined using an improved Lowry assay (Dc protein assay,
Biorad). C-Nap1 antibodies were rabbit polyclonal C-Ab (aa 1982-
2442) and M-Ab (aa 1098-1248) (Fry et al., 1998a; Mayor et al.,
2000). All antibody incubations were carried out in blocking buffer
(5% nonfat dried milk in PBS/0.1% Tween-20) at the following
dilutions: C-Ab, 0.5 m g/ml; M-Ab, 1 m g/ml; anti-cdc27 serum,
1/1000; anti-cyclin A, 1/500; anti- a -tubulin mAb, 1/1000 (Sigma);
anti-GFP mAb, undiluted tissue culture supernatant. Bound IgGs were
visualized using alkaline phosphatase-conjugated anti-rabbit or anti-
mouse IgG secondary antibodies (1:7500; Promega). 
Alkaline phosphatase treatment
HeLa cells were lysed in IP buffer (0.5% Igepal, 150 mM NaCl, 50
mM Tris-HCl pH 8, 20 mM b -glycerophosphate, 20 mM NaF and 0.3
mM NaVO4). Samples containing equal amounts of proteins were
mixed for 1 hour at 4°C with C-Ab (8 m g/ml) pre-bound to Affiprep
protein A beads (1 m l/m g of Ab; Biorad). Beads were washed three
times with IP buffer and resuspended in 2 · 200 m l of AP buffer (10
mM Tris-HCl, 10 mM MgCl2, 50 mM NaCl, 1 mM DTT, pH 7.9, with
1 mM PMSF, 1 m g/ml aprotinin, 1 m g/ml leupeptin and 1 m g/ml
Journal of Cell Science 115 (16)
3277C-Nap1 dissociation from centrosome
pepstatin). Reactions were then carried out by incubating these 200
m l aliquots for 40 minutes at 37°C with 20 units of either active or
heat-inactivated (10 minutes at 95°C) calf intestinal alkaline
phosphatase (M0290; New England BioLabs). Finally, beads were
resuspended in sample buffer.
In vivo [32P] labeling
HeLa cells in G1 were collected 4 hours after release from a 16 hour
nocodazole block. Cells in S, G2 and M phase were obtained after
releases for 2, 6 or 10 hours, respectively, from a double-block with
thymidine-aphidicolin. M-phase cells were further blocked with
nocodazole for an additional 5 hours and then collected by mechanical
shake-off. All cells were labeled by additional incubation for 4 hours
in phosphate-free DMEM medium that had been supplemented with
10% dialyzed FCS, 10% normal DMEM, 1% normal FCS and 400
m Ci/ml of phosphoric acid (1 mCi in total). Cells were collected and
lysed in 400 m l/2 · 106 cells of modified-IP buffer (0.4% Igepal, 0.1%
deoxycholic acid, 150 mM NaCl, 50 mM Tris-HCl pH 8, 20 mM b -
glycerophosphate, 20 mM NaF and 0.3 mM NaVO4). Orthophosphate
incorporation in the various cell extracts was measured by scintillation
counting, and equal protein levels were confirmed by Coomassie blue
staining. Samples were then pre-cleared using rabbit IgG bound to
Protein A-Dynabeads (Dynal, 10 m g IgG to 40 m l beads/400 m l
extract), and immunoprecipitations were performed with C-Ab (and
rabbit IgG for control) bound to Protein A-Dynabeads pre-blocked
with HeLa cell extracts (5 m g IgG to 20 m l beads/200 m l extract). To
ensure low background, samples were resuspended in sample buffer
(30 m l), heated for 5 minutes at 95°C, diluted in 1 ml of modified-IP
buffer and subjected to a second round of immunoprecipitation.
Miscellaneous techniques
Immunoelectron microscopy was performed as described previously
(Fry et al., 1998a). For assaying protein degradation, cyclin B2 and
myc-C-Nap1 were in vitro translated, in the presence of [35S]-Met
(TNT coupled reticulocyte system, Promega), and added to M-phase
Xenopus egg extracts (12.5% of final volume). These were prepared
by complementing interphasic extracts with recombinant D 90-cyclin
B and cycloheximide (0.25 m g/m l), followed by a 90 minute incubation
at 22°C (Vorlaufer and Peters, 1998). Aliquots were removed every
15 minutes, mixed with sample buffer and heated for 5 minutes at
95°C.
Results
Cell cycle analysis of C-Nap1 protein levels
To determine whether C-Nap1 levels are regulated during the
cell cycle, HeLa cells were synchronized at different cell cycle
stages. Equal amounts of protein were then resolved by SDS-
PAGE and analyzed by western blotting. Compared with
asynchronous, G1 or G2 cells, the C-Nap1 signal was
significantly diminished in the M-phase sample (Fig. 1A). This
reduction in C-Nap1 signal was highly reproducible and
independent of the antibody used for detection (data not shown,
but see Fig. 1C and Fig. 2A). Equal sample loading was
confirmed by western blotting with a -tubulin antibodies
(Fig. 1A) and Coomassie blue staining (data not shown). As
a direct control for the M-phase state, western blotting
was also performed with antibodies against Cdc27, a
subunit of the APC/cyclosome complex that displays a
reduced electrophoretic mobility upon M-phase-specific
phosphorylation (Fig. 1A). Cell cycle arrest experiments were
also performed using monastrol. This drug inhibits the kinesin-
related motor Eg5 and thus arrests cells in early mitosis with
monopolar spindles, without disturbing MTs (Mayer et al.,
1999; Kapoor et al., 2000). As shown in Fig. 1B, the C-Nap1
protein signal was reduced to a similar extent, regardless of
whether cells had been arrested with monastrol or nocodazole.
Furthermore, no C-Nap1 could be detected in any of the
insoluble fractions, arguing against cell cycle variability in C-
Nap1 extractability (Fig. 1B). Finally, mitotic cells were also
collected by mechanical shake off, and samples analyzed by
western blotting using antibodies directed against either the C-
terminus (C-Ab) or the central domain (M-Ab) of C-Nap1. In
all these experiments, the C-Nap1 signal was reduced by about
30-40% in M-phase cells when compared with asynchronously
growing cells (Fig. 1C).
Fig. 1. Loss of C-Nap1 staining during mitosis. (A) HeLa cells were
synchronized at the indicated cell cycle stages. Equal amounts of
protein were then separated by 10% SDS-PAGE and probed by
immunoblotting with the antibodies indicated. (B) HeLa cells were
collected in G2 or blocked in mitosis using either nocodazole or
monastrol, as indicated. Equal amounts of protein were separated by
7.5% SDS-PAGE, and probed by immunoblotting. For the control,
insoluble fractions were also resuspended and corresponding
volumes (1:1) analyzed in parallel. (C) Mitotic HeLa cells (M) were
collected by mechanical shake off and asynchronously growing cells
(asy) by trypsinization. Levels of C-Nap1 were then determined by
immunoblotting, using either C-Ab or M-Ab (Fry et al., 1998a;
Mayor et al., 2000). All C-Nap1 signals were standardized relative to
the a -tubulin signal. The histogram shows the relative levels of C-
Nap1 in M-phase and asynchronously growing cells.
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The above results suggested that C-Nap1 could be subject to
cell-cycle-regulated proteolytic degradation. To determine
whether the inhibition of the proteasome would result in a
stabilization of C-Nap1, M-phase arrest experiments were
performed in the presence of increasing amounts of the
proteasome inhibitor MG132. As shown in Fig. 2A, C-Nap1
levels were reduced even in the presence of this inhibitor. In
contrast, the proteasome-target cyclin A was stabilized, as
expected, demonstrating the efficacy of proteasome inhibition
(Fig. 2A). Virtually identical results were obtained using the
proteasome inhibitors MG115 and N-acetyl-leucyl-leucyl-
norleucinal (ALLN) (data not shown). In principle, C-Nap1
could be a substrate for other proteases, but we emphasize that
no distinct cleavage products could ever be observed in any of
the above experiments. To more directly assess C-Nap1 stability
during M phase, we turned to Xenopus egg extracts, which
provide a convenient assay system for examining protein
degradation (Vorlaufer and Peters, 1998). When [35S]-labeled, in
vitro translated C-Nap1 and cyclin B were added to such
extracts, C-Nap1 was completely stable, whereas cyclin B was
almost totally degraded after 60 minutes of incubation (Fig. 2B).
Taken together, these results indicate that C-Nap1 is not subject
to degradation by the proteasome, and they also argue against
cleavage of C-Nap1 by other M-phase-specific proteases.
Evidence for M-phase-specific phosphorylation of C-Nap1
As the fate of mitotic C-Nap1 did not seem to be governed by
proteolytic degradation, we next considered the possibility that
the M-phase-specific reduction in the C-Nap1 signal could
reflect a post-translational modification. In particular, we
reasoned that M-phase-specific phosphorylation might have
caused an altered, more diffuse electrophoretic mobility of C-
Nap1, or a reduced transfer to nitrocellulose membranes. To
explore this possibility, C-Nap1 was immunoprecipitated from
extracts at different cell cycle stages, and then treated with calf
intestinal phosphatase prior to western blotting. As shown in
Fig. 3A, the staining of mitotic C-Nap1 was increased in
response to active phosphatase but not the heat-inactivated
enzyme. Similar results were obtained when mitotic cell
extracts were incubated at 37°C in the absence of phosphatase
inhibitors (data not shown). These data show that a near-
interphasic C-Nap1 signal could be recovered by treatment of
mitotic C-Nap1 with an active phosphatase, implying that C-
Nap1 was phosphorylated when isolated from mitotic cells. 
To directly demonstrate that C-Nap1 is phosphorylated
during mitosis, in vivo labeling with [32P]phosphoric acid was
performed in HeLa cells. Extracts were then prepared
from different cell cycle stages, and C-Nap1 was
immunoprecipitated and analyzed by SDS-PAGE. As shown
by autoradiography and western blotting, immunoprecipitated
C-Nap1 was labeled with [32P] specifically during M phase,
but not during G1, S or G2 phases (Fig. 3B). No [32P]-labeling
of C-Nap1 was observed in control immunoprecipitation
experiments using nonspecific rabbit IgG (data not shown).
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Fig. 2. C-Nap1 is not degraded during mitosis. (A) HeLa cells were
collected in G2 or blocked in mitosis in the presence or absence of
the proteasome inhibitor MG132. Equal amounts of protein were
separated by 7.5% SDS-PAGE and probed by immunoblotting using
the antibodies indicated. (B) Destruction assay in Xenopus egg
extract. [35S]-labeled cyclin B and C-Nap1 were added to a mitotic
extract and samples taken at the indicated times (minutes). Proteins
were separated by 10% SDS-PAGE and exposed for autoradiography. 
Fig. 3. C-Nap1 is phosphorylated during mitosis. (A) Alkaline
phosphatase treatment enhances the western blot signal of mitotic C-
Nap1. C-Nap1 was immunoprecipitated from asynchronously
growing (asy) or nocodazole-arrested (noc) HeLa cells and treated
with either active (+) or heat-inactivated (–) calf intestinal
phosphatase (CIP). Samples were separated by 7.5% SDS-PAGE and
probed by immunoblotting as indicated (IgG are shown to
demonstrate equal loading). (B) In vivo labeling of C-Nap1 with
[32P]orthophosphate. C-Nap1 was immunoprecipitated from the
indicated cell cycle stages, using C-Ab. Samples were separated by
7.5% SDS-PAGE, and gels exposed for autoradiography (top panel).
In parallel, recovery of C-Nap1 was controlled by western blotting
with C-Ab (bottom panel).
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Taken together, these data indicate that C-Nap1 is indeed
phosphorylated specifically during mitosis.
Overexpression of C-Nap1 causes the formation of large
centrosome-associated structures
The above results strongly suggested that phosphorylation,
rather than proteolysis, regulates the displacement of C-Nap1
from the centrosome at the onset of mitosis. However, because
only a fraction of the total C-Nap1 protein (estimated to about
30-50%) is associated with the centrosome, it is difficult to
obtain definitive information about local events occurring at the
centrosome. As a complementary approach to studying the fate
and regulation of C-Nap1 during the cell cycle, we thus
decided to examine the phenotypic consequences of
overexpressing C-Nap1 in human cells. In particular, we asked
whether a high level of C-Nap1 could prevent the dissociation
of C-Nap1 from the centrosome, and thus possibly interfere
with centrosome separation at the onset of mitosis. Full-length
C-Nap1, with or without an N-terminal myc-tag, was therefore
placed under the control of a CMV promoter and transiently
transfected into U2OS cells. Then, the localization of
the ectopically expressed protein was determined by
immunofluorescence microscopy. In parallel, the distribution
and morphology of centrosomes was examined by staining
with antibodies against g -tubulin. In cells expressing low levels
of exogenous C-Nap1, the full-length protein localized
correctly and almost exclusively to the centrosome (data not
shown). With higher expression levels, however, cytoplasmic
staining became increasingly prominent, and, most strikingly,
one or several compact C-Nap1-positive aggregates (termed
patches) became visible (Fig. 4A). In some cells, these patches
grew into large structures occupying almost the entire
cytoplasm. Immunoelectron microscopy performed on cells
overexpressing C-Nap1 revealed that the centrioles were
invariably embedded in large structures showing extensive
labeling with anti-C-Nap1 antibodies (Fig. 4B). These
structures often emanated primarily from the proximal ends of
centrioles (Fig. 4Ba), but eventually extended to engulf almost
the entire centrioles (Fig. 4Bb). 
To further characterize the relationship between the
observed C-Nap1 patches and centrosomes, antibodies against
different centrosomal proteins were used for double
immunofluorescence microscopy. Endogenous Nek2 protein
was found to accumulate rather uniformly in all C-Nap1
patches (Fig. 5Ab), consistent with a direct interaction between
these two proteins (Fry et al., 1998a). In contrast, the
distribution of g -tubulin appeared largely unaltered, in that anti-
g -tubulin antibodies stained the typical one or two dots per cell
(Fig. 5Ac). In cases where only a single C-Nap1 patch was
present within a cell, this patch was invariably associated with
the g -tubulin-positive centrosome. However, if multiple
patches were present, only one stained positive for g -tubulin
(Fig. 5A). Similar results were obtained for other centrosome-
associated proteins, notably centrin-2, p150Glued and Plk1, with
none of them showing a particular enrichment in the C-Nap1
patches (data not shown). These results indicate that the
observed patches are composed primarily of C-Nap1 itself, and
that they incorporate at most a limited subset of endogenous
centrosomal proteins. Consistent with this interpretation, none
of the extra-centrosomal C-Nap1 patches displayed any
microtubule (MT) nucleation activity. On the contrary, a MT
re-growth assay showed that centrosomes embedded in C-
Nap1 patches displayed severely reduced MT nucleation
activity (Fig. 5B). It seems plausible that this reflects steric
hindrance exerted by the C-Nap1 oligomer.
In order to identify sub-domains within C-Nap1 responsible
for patch formation, several truncation mutants of C-Nap1
were expressed in U2OS cells (Fig. 5C). We found that a
mutant from which only the C-terminal domain had been
deleted (T4) still formed extensive patches, but that further
deletion of the C-terminal coiled-coil domain (T5) abolished
patch formation. Furthermore, none of the mutants (T6, T7)
lacking the N-terminal end domain formed patches. These data
suggest that self-assembly of C-Nap1 into oligomeric
structures requires the N-terminal end domain and both central
coiled-coil domains.
Overexpression of C-Nap1 does not prevent centrosome
separation
Next we sought to determine whether the overexpression of C-
Fig. 4. Overexpression of full-
length C-Nap1 causes patch
formation. U2OS cells were
transiently transfected with
full-length C-Nap1 and, 24





microscopy (A), cells were
fixed with methanol; for
immunoelectron microscopy
(B) cells were fixed with 3%
paraformaldehyde/2% sucrose.
C-Nap1 overexpression
resulted in the formation of
single (a) or multiple (b)
patches. The arrowhead in Ab points to the patch containing the centrosome, as determined by counter-staining with anti- g -tubulin antibodies
(not shown). Bars, 10 m m (Ab); 250 nm (Bb). 
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Nap1 would deregulate centrosome
separation and/or cell cycle progression.
Initial experiments based on flow
cytometry failed to reveal any significant
differences between the cell cycle profiles
of populations transfected with either C-
Nap1 or pBK-CMV empty vector (data
not shown). To ask more directly whether
C-Nap1 overexpression would prevent
entry of cells into mitosis, C-Nap1 was co-
expressed with a non-destructible mutant
of cyclin B2, which is known to cause the
accumulation of mitotic cells (Gallant and
Nigg, 1992). If the observed embedding of
centrosomes into large C-Nap1 patches
was to block entry of cells into mitosis, co-
expression of C-Nap1 should have
suppressed the accumulation of mitotic
cells. However, this was not observed:
upon co-expression of C-Nap1 with non-
destructible cyclin B2, about 50% of the
transfected cells arrested in mitosis (Fig.
6A). This extent of mitotic arrest was
similar to that seen in control experiments,
in which non-destructible cyclin B2 was
co-transfected with the enhanced GFP
marker alone (Fig. 6A). Conversely, the
accumulation of mitotic cells was severely
suppressed upon co-expression of the non-
destructible cyclin B2 with a dominant-
negative Cdk1 mutant. As this Cdk1
mutant is known to cause a G2 arrest (van
den Heuvel and Harlow, 1993), this result
validates our experimental approach and
establishes that overexpression of C-Nap1
does not prevent cells from entering
mitosis.
From the above results it is difficult to
escape the conclusion that cells were able
to undergo mitosis in spite of the fact that
their interphase centrosomes were
embedded in large C-Nap1 structures.
This begs the question of how such
embedded centrosomes could separate and
contribute to the formation of a functional
mitotic spindle. To address this issue, we
established a U2OS cell line stably expressing a full-length
GFP-C-Nap1 fusion protein under tetracycline control. Within
24 hours of tetracycline addition, exogenous GFP-C-Nap1 was
readily expressed, as demonstrated by western blotting (Fig.
6B). When analyzed by fluorescence microscopy, GFP-C-
Nap1 formed patches that were indistinguishable from those
described above (data not shown, but see below). The stably
transformed U2OS cells were then grown for 6 days in the
presence or absence of tetracycline, and their growth curves
determined. In a third U2OS cell population, GFP-C-Nap1
expression was pre-induced for 24 hours, before the culture
was continued for 6 days in the presence of tetracycline. As
shown in Fig. 6C, all three cell lines showed indistinguishable
proliferation rates, confirming that cells proliferate normally in
the presence of extensive C-Nap1 patches. To further test this
surprising conclusion, we directly examined spindle formation
in cells harboring C-Nap1 patches. Spindle MTs were stained
with antibodies against a -tubulin (Fig. 7A), whereas centrioles
were stained with antibodies against poly-glutamylated tubulin
[GT335 (Wolff et al., 1992; Bobinnec et al., 1998)] (Fig.
7Ba,b), and centrosomes with antibodies against g -tubulin
(Fig. 7Bc). At the level of resolution provided by
immunofluorescence microscopy, no obvious defects in
centrosome migration, spindle formation or chromosome
segregation could be detected (Fig. 7b,c). However, a most
remarkable change occurred in the relationship between
centrosomes and C-Nap1 patches. Whereas all interphase
centrosomes were embedded in C-Nap1 patches (Fig. 7Aa,
Ba), none of the mitotic spindle poles seen in metaphase,
anaphase or telophase cells ever showed any association with
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Fig. 5. Protein recruitment to C-Nap1 patches. (A) U2OS cells were transfected with either
myc-C-Nap1 or C-Nap1 and fixed with methanol 24 hours later. In the former case, they
were stained with a monoclonal anti-myc antibody (9E10) for C-Nap1 (a) and
counterstained with a rabbit anti-Nek2 antibody (b). In the latter case, C-Nap1 was stained
with C-Ab (c), and g -tubulin was visualized with a monoclonal antibody (d). No signal was
observed in cells stained with either anti-rabbit or anti-mouse secondary antibodies alone
(data not shown). Bar, 10 m m (d). (B) MT re-growth assay. Following overexpression of C-
Nap1, MTs were depolymerized by cold treatment, and MT re-polymerization was induced
for 60 seconds by placing cells into pre-warmed medium (37°C). Cells were then fixed with
methanol and stained with C-Ab (a) and a mouse anti- a -tubulin antibody (b). The
arrowhead points to a transfected cell harboring a C-Nap1 patch; note that MT nucleation is
severely suppressed in this cell. Bar, 10 m m (b). (C) Mutational domain analysis of C-Nap1.
On the right, the C-Nap1 domain structure and the ability of different C-Nap1 deletion
mutants to form patches is summarized schematically. The dark boxes designate the
predicted coiled-coil domains in C-Nap1; wt (wild-type) denotes the full-length C-Nap1
protein. On the left, the phenotype observed after overexpression of the T4 C-Nap1 deletion
mutant is illustrated. U2OS cells were analyzed by immunofluorescence microscopy, using
anti-myc (9E10) antibodies for staining of T4. Bar, 10 m m. 
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such patches (Fig. 7Ab,c, Bb,c, and data not shown). In
contrast, C-Nap1 patches that were not in direct contact with
centrosomes persisted in the cell body throughout mitosis (Fig.
7). Most interestingly, we also observed several examples of
prophase cells in which one centrosome was still embedded
within a C-Nap1 patch, whereas the other was already free and
positioned at some distance (Fig. 7C). The one C-Nap1 patch
that was still in contact with a centrosome often appeared
disturbed and partially dissolved (Fig. 7C, see enlarged insets).
Virtually identical results were obtained when examining cells
after transient overexpression of a non-tagged version of C-
Nap1 (data not shown), indicating that the GFP marker was not
responsible for the loss of C-Nap1 interaction with mitotic
spindle poles. From these results we conclude that the
centrosome-associated C-Nap1 patches are subject to
disassembly at the very onset of mitosis, when chromosome
condensation begins and centrosomes separate. Furthermore,
our observations strongly argue against a generalized
mechanism for the disassembly of C-Nap1-containing
structures. Instead, they point to a mechanism that is activated
specifically at the centrosome. As a consequence, centrosome-
associated C-Nap1 structures are locally dismantled, allowing
centrosome separation and spindle formation to occur,
although C-Nap1 patches elsewhere in the cell persist
throughout mitosis. 
Active Nek2 interferes with C-Nap1 patch formation
In previous studies, we have shown that the centrosome-
associated protein kinase Nek2 can bind and phosphorylate C-
Nap1, both in vitro and in vivo (Fry et al., 1998b). Here, we
have shown that C-Nap1 is almost certainly phosphorylated
during M phase, and that overexpressed C-Nap1 is specifically
removed from centrosomes at the onset of mitosis. Therefore,
it was of obvious interest to ask whether co-expression of Nek2
would influence the formation or stability of C-Nap1 patches.
To this end, C-Nap1 was co-expressed with either wild-type
Nek2 or a catalytically inactive Nek2 mutant. Then, cells were
scored for the frequency and appearance of C-Nap1 patches
(Fig. 8A). To facilitate data analysis, transfected cells were
grouped into three classes, depending on the observed C-Nap1
distribution (Fig. 8B). The first class comprised cells showing
little, if any, unusual C-Nap1 structures (Fig. 8Ba). In the
second class, we counted cells with one or few (<10) large
patches (Fig. 8Bb), and in the third class cells harboring many,
often small C-Nap1-positive patches (>10) or speckles (Fig.
8Bc). Using this classification, we observed a very striking
effect of active, but not inactive Nek2, on the formation of C-
Nap1-positive structures. Cells expressing the catalytically
inactive Nek2 mutant in fact contained predominantly class II
cells with few but large C-Nap1 patches (Fig. 8A), as observed
for cells transfected with C-Nap1 only (see above). In contrast,
Fig. 6. C-Nap1 overexpression does not prevent cell cycle progression. (A)
U2OS cells were co-transfected with two plasmids, one encoding a non-
destructible cyclin B2 mutant and the second C-Nap1, GFP or Cdk1-DN, as
indicated. At 36 hours post-transfection, cells were fixed and the percentages of
cells in interphase (black bars) and mitosis (light gray bars) determined.
Transfected cells were detected using the 9E10 mAb for C-Nap1 and anti-HA
mAb for Cdk1-DN. Enhanced GFP was detected using the FITC filter. In two
independent experiments, more than 200 cells were counted. (B) Integration and
expression of GFP-C-Nap1 in TREx modified U2OS cells. Expression of the
fusion protein was induced for 24 hours with 1 m g/ml tetracycline. Induced (i) or
uninduced (u) cells were lysed directly in sample buffer, and extracts were
analyzed by immunoblotting using the indicated antibodies. The positions of
molecular weight markers are indicated (in kDa) and the arrowhead marks C-
Nap1. (C) Growth rates were determined for stable cell lines in which the
expression of GFP-C-Nap1 had not been induced (uninduced), or induced (1
m g/ml tetracycline) at either time 0 (induced) or 24 hours before the initiation of
the experiment (pre-induced). Cells were collected at the times indicated and
counted.
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the presence of active Nek2 strikingly diminished the
frequency of cells with large C-Nap1 structures, and instead,
most cells now fell into class III, showing a multitude of small
C-Nap1-positive speckles (Fig. 8A). We interpret this
observation to indicate that Nek2 kinase activity interfered
with the formation of large C-Nap1 aggregates, thereby
favoring the formation of a multitude of small C-Nap1
structures. Although obtained in an artificial experimental
setting, these results support the view that C-Nap1 is an in vivo
substrate of Nek2, and that Nek2 activity may thus be
responsible for the dissociation of C-Nap1 from mitotic spindle
poles. 
Discussion
C-Nap1 is phosphorylated during mitosis, not degraded
In the first part of the present study, we have examined the fate
of C-Nap1 protein upon entry of cells into mitosis. In
particular, we have sought evidence to suggest an involvement
of either proteolysis or phosphorylation in the dissociation of
C-Nap1 from mitotic centrosomes. From western blotting data,
it appeared that total C-Nap1 protein levels were diminished
by as much as 30-40% in mitotic extracts, when compared with
levels in interphasic extracts. However, inhibition of the
proteasome did not prevent this apparent reduction in C-Nap1
levels, arguing against an involvement of ubiquitin-dependent
proteolysis. Furthermore, C-Nap1 was stable in Xenopus M-
phase extracts, and no specific cleavage products could be
observed. Thus, at the present time there is no evidence to
support a role for proteolysis in the regulation of C-Nap1
levels. Instead, our data suggest that C-Nap1 dissociates from
centrosomes as a result of phosphorylation. First, when C-
Nap1 was immunoprecipitated from M-phase extracts and then
treated with alkaline phosphatase prior to western blotting, the
signal intensity was restored to the levels seen for interphasic
C-Nap1. It seems most likely that the observed reduction in
signal intensity was due to a reduced efficiency in the transfer
of phosphorylated C-Nap1 to nitrocellulose membranes, as
similar reductions in signal intensity were also seen upon
phosphorylation of recombinant C-Nap1 by the Nek2 protein
kinase (T.M. and E.A.N., unpublished). Second, direct in vivo
labeling studies with [32P] indicate that endogenous C-Nap1
is phosphorylated in a cell-cycle-regulated manner, with
maximal phosphorylation occurring during M phase.
Therefore, we conclude that the dissociation of C-Nap1 from
mitotic centrosomes is most likely triggered by C-Nap1
phosphorylation rather than proteolysis.
C-Nap1 can self-assemble into large structures
In a second, complementary approach, we have examined the
consequences of overexpressing C-Nap1 in human cells. The
main purpose of these experiments was to ask whether
deregulated expression of C-Nap1 would interfere with
centrosome separation at the onset of mitosis, and thus possibly
block mitotic progression. We found that exogenous C-Nap1
formed large structures (termed patches) within the cell
cytoplasm. The first of these patches invariably assembled
around the centrosome, but with increasing C-Nap1 levels,
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Fig. 7. Cells overexpressing GFP-C-Nap1 establish functional
mitotic spindles. (A) GFP-C-Nap1 expression was induced for 24
hours and cells were stained for MTs in red (anti-a -tubulin mAb),
DNA in blue (Hoechst dye) and C-Nap1 in green (GFP
fluorescence). Representative cells are shown in interphase (a),
metaphase (b) and anaphase (c). Bars, 10 m m. (B) Further
immunofluorescent analysis of GFP-C-Nap1-expressing cells.
Staining in red shows poly-glutamylated tubulin that predominantly
localizes to centrioles (GT335; a,b) and spindle poles (anti- g -tubulin;
c); staining in blue shows DNA and in green shows C-Nap1. Shown
are representative cells in interphase (a) and mitosis (b,c). Bar, 10
m m. (C) Prophase cells were stained in red for a -tubulin (a) and g -
tubulin (b), in blue for DNA and in green for C-Nap1. Enlarged (2· )
insets of the C-Nap1 patches surrounding the centrosome are shown
in black and white (b); z0 and z1 designate two different focal planes.
Bar, 10 m m.
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additional patches formed throughout the cytoplasm. Of
several centrosome-associated proteins examined (Nek2, g -
tubulin, centrin-2, Plk1, p150Glued), only Nek2 was recruited
to a significant extent to the C-Nap1 patches. This underscores
the affinity of Nek2 for C-Nap1, but also suggests that
ectopically expressed C-Nap1 interacts largely with itself,
recruiting at most a limited subset of centrosomal proteins into
the patches. As shown by a MT re-growth assay, C-Nap1
patches interfered with MT-nucleation activity. We believe that
this reflects steric hindrance rather than a direct role of C-Nap1
in MT-nucleation. Conversely, no increased MT-nucleation
activity could be observed, in line with the view that C-Nap1
plays a structural role at the centrosome. 
Although the C-Nap1 patches described here clearly
represent non-physiological structures, they are reminiscent of
aberrant centrosome-related structures that occur in human
tumors. Centrosomal aberrations have long been described in
human cancers (Boveri, 1914), and more recently were shown
to include supernumerary centrioles, excess pericentriolar
material and fragmented centrosomal structures (for reviews,
see Lingle and Salisbury, 2000; Brinkley, 2001; Duensing and
Munger, 2001; Doxsey, 2001). If C-Nap1 overexpression were
to occur under pathological conditions, our present results
predict that this would probably not affect cell division.
However, considering that centrosomes play an important role
in organizing the microtubule network also during interphase
of the cell cycle, it would be premature to exclude that aberrant
centrosomal structures formed by C-Nap1 and other structural
proteins could interfere with MT-dependent processes such as
cell shape, polarity or motility. 
C-Nap1 patches are dismantled around centrosomes
during prophase
Considering the extensive embedding of centrosomes into C-
Nap1 patches, and the concomitant suppression of MT
nucleation, we were surprised to find that C-Nap1 patches did
not detectably interfere with cell proliferation. However,
detailed examination of the fate of C-Nap1 patches during the
cell cycle offered an explanation for this apparent paradox:
staining of centrosomes with appropriate antibodies in fact
revealed that centrosomes are extracted from the embrace of
C-Nap1 patches during early prophase. As a result, bipolar
spindles readily formed, and spindle poles were never
embedded within C-Nap1 patches. In striking contrast, C-Nap1
patches that were not in direct contact with centrosomes
persisted throughout cell division. These results strongly
suggest that centrosomes harbor an activity that, at the onset
of mitosis, can trigger the local disassembly of C-Nap1. As
suggested previously (Fry et al., 1998a), the protein kinase
Nek2 is a prime candidate for providing such an activity. This
notion was further corroborated here by our demonstration that
co-expression of Nek2 with C-Nap1 profoundly affected the
formation of C-Nap1 patches, strongly indicating that Nek2 is
able to phosphorylate C-Nap1. 
Although attractive, the idea that Nek2 triggers C-Nap1
dissociation from centrosomes is confounded by two problems:
first, as we have shown here, Nek2 is recruited to all C-Nap1
patches, and yet only the centrosome-associated patch
disassembles at the onset of mitosis. Hence, another
centrosome-associated activity may be limiting for C-Nap1
disassembly. Alternatively, our observations could be
explained if the Nek2 antagonist PP1 was also recruited to C-
Nap1 patches, but only inactivated by Cdk1/cyclin B at the
centrosome. Although we presently have no appropriate
antibodies to test whether PP1 is recruited to C-Nap1 patches,
the observed centrosome-association of Cdk1/cyclin B (Bailly
et al., 1992) would be consistent with such a scenario. A
second problem stems from the previous finding that Nek2
protein and activity levels are strongly reduced in nocodazole
arrested cells (Fry et al., 1995). At first glance, this would seem
to argue against Nek2 being the kinase responsible for
phosphorylating C-Nap1 in the experiments described here.
However, we emphasize that recent studies have revealed the
existence of two alternatively spliced forms of Nek2, Nek2A
and Nek2B, not only in Xenopus (Fry et al., 2000; Uto and
Sagata, 2000) but also in human cells (Hames et al., 2001).
Although Nek2A is degraded in nocodazole-arrested cells, due
Fig. 8. Active Nek2 modulates C-Nap1 patch
formation. (A) Histograms illustrate the percentage
of transfected cells falling into three defined
categories (as defined in B), after co-transfection of
mycC-Nap1 with either active Nek2 (Nek2-wt) or a
catalytically inactive Nek2 mutant (Nek2-K37R).
Results are shown as averages of two independent
experiments. (A total of 588 cells were counted for
co-transfections with Nek2-K37R and 600 cells for
co-transfections with Nek2-wt.) (B) Representative
examples of three types of C-Nap1 structures, used
for classification of transfected cells. Class I, C-
Nap1 localized to centrosomes without inducing the
formation of grossly abnormal structures (a). Class
II, C-Nap1 formed one predominant patch closely
associated with the centrosome, with or without
accompanying smaller patches (<10 patches in total)
(b). Class III, C-Nap1 formed many (>10), often
small, patches (speckles) (c). Bar, 10 m m (Ac).
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to ubiquitin-dependent proteolysis, Nek2B is stable (Hames et
al., 2001). Thus, this newly discovered, shorter form of the
Nek2 kinase could readily continue to phosphorylate C-Nap1
even after the destruction of Nek2A. To definitively prove that
Nek2A and/or B is the kinase responsible for C-Nap1
disassembly, it will be necessary to identify the in vivo
phosphorylation sites within C-Nap1 and compare them with
the sites phosphorylated by Nek2 in vitro. So far, all our
attempts at identifying in vivo phosphorylation sites within C-
Nap1 have been unsuccessful, at least in part due to low protein
abundance. However, with the increasing sensitivity of mass
spectrometry, it seems legitimate to hope that this goal may
come within reach in the not too distant future.
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